Frequent coauthors
The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy…
The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy…
The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy…
The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy…
The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy…
The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy…
The use of coagulation factor VII-activating protease (FSAP) for the prophylaxis and/or therapy of vasoproliferative disorders or oncoses is described. Reference is made in particular to the use of the protease for retinopathy, neuropathy…
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…
Use of blood factor 7-activating protease for the prevention and treatment of vasoproliferative diseases e.g. rheumatoid arthritis, psoriasis, endometriosis, bronchitis Use of blood factor VII-activating protease (FSAP) for prevention and/o…